FDA Approves Ampyra to Improve Walking in Adults with Multiple Sclerosis
Submitted by drgunasakaran1 on Sat, 01/23/2010 - 04:00The U.S. Food and Drug Administration today approved Ampyra (dalfampridine) extended release tablets to improve walking in patients with multiple sclerosis (MS). In clinical trials, patients treated with Ampyra had faster walking speeds than those treated with an inactive pill (placebo). This is the first drug approved for this use.

